Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001681:Biological Assay; D002330:Carmustine / Q000627:therapeutic use; D003510:Cyclohexanes; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008558:Melphalan / Q000627:therapeutic use; D051379:Mice; D008806:Mice, Inbred AKR; D009101:Multiple Myeloma / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009607:Nitrosourea Compounds; D003561:Cytarabine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D008558:Melphalan; D005472:Fluorouracil; D002330:Carmustine; D011241:Prednisone; D003630:Daunorubicin